Related Experiment Video
Updated: May 3, 2026
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
1.5K
Obesity in women
Donna H Ryan1, Jill Braverman-Panza
1Pennington Biomedical Research Center, Baton Rouge, LA, USA.
The Journal of Family Practice
|February 15, 2014
Summary
Obesity affects 1 in 3 women and requires chronic disease management. Multimodal therapy, including behavioral changes and medications, aids in achieving and maintaining weight loss.
Area of Science:
- Endocrinology
- Public Health
- Internal Medicine
Background:
- Obesity is a prevalent chronic disorder impacting a significant portion of the female population.
- Effective management strategies are crucial for addressing the health implications of obesity.
Purpose of the Study:
- To outline the comprehensive assessment and management of obesity.
- To highlight the role of multimodal therapy in addressing this chronic condition.
Main Methods:
- Assessment involves measuring Body Mass Index (BMI) and waist circumference.
- A detailed patient history covering nutrition, physical activity, and weight loss history is essential.
- Identification of obesity-related comorbidities guides treatment decisions.
Main Results:
- Obesity necessitates a chronic care model approach.
- Multimodal therapy, combining behavioral interventions with pharmacotherapy, is effective.
- Medications like lorcaserin, orlistat, and phentermine/topiramate support weight loss and maintenance.
Conclusions:
- Obesity management requires a sustained, multifaceted approach.
- Behavioral therapy is a cornerstone of treatment, enhanced by pharmacologic options.
- Long-term strategies are key for successful weight management in patients with obesity.
More Related Videos
11:44A Primary Human Trophoblast Model to Study the Effect of Inflammation Associated with Maternal Obesity on Regulation of Autophagy in the Placenta
Published on: September 27, 2017
11.2K
03:35Determining Gender-Based Differences in Retinal and Choroidal Thickness in Underweight Individuals via Swept-Source Optical Coherence Tomography
Published on: December 1, 2023
853
Related Concept Videos
01:24Obesity
1.5K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
01:21Drug Dosing: Obese Patients
368
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
368
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
440
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
440
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
324
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
324
01:24Disorders of the Female Reproductive System
4.5K
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
4.5K
01:30Bulimia Nervosa
1.1K
Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
1.1K